Abstract
The mosaic ecosystems of microbes that live on our skin encompasses not only bacteria but also fungi, microeukaryotes, and viruses. As the second most prevalent group, unique fungal communities are found across the dry, moist, and oily microenvironments of human skin, and alterations of these communities is largely driven by changes in skin physiology throughout an individual’s lifespan. Fungi have also been associated with infection and dermatological disorders, resulting from the disrupted balance between fungal-bacterial networks on the skin. Mechanisms of colonization resistance towards fungi in the skin microbiome of animals have advanced our understanding in conservation strategies yet in the human skin, the fungal microbiome (mycobiome) remains vastly unexplored. Here, we review recent studies on the role of fungi in the skin microbiome, emphasizing how fungal-bacterial interactions at the skin surface play an important ecological function in vertebrate hosts.
Introduction
Diverse microbial communities composed of bacteria, fungi, viruses and microeukaryotes live on human skin, which is collectively called the skin microbiome. Skin pores and appendages such as hair follicles and sebaceous glands provide safe harbor for these communities, representing one of the largest direct epithelial interfaces facilitating host-microbe interactions. The skin microbiome serves to fortify the primary barrier function of the skin both by directly warding off invading pathogens and tuning the immune system starting early in life [1,2]. A unique feature of the skin is the diversity of microenvironments across the body. Sites such as the forearm are drier and more desiccate, while the umbilicus (navel) and axilla (arm pit) retain a high moisture content, and sites like the forehead are oily. In turn, these features help shape the structure of associated microbial communities [3] and offer an unprecedented opportunity to study microbial ecology on the human body. Indeed, the skin is an ideal system because it is amenable to repeat sampling and longitudinal sampling over the lifespan of an individual and across the biogeography of the body.
While the skin microbiome is relatively understudied compared to the gut microbiome, significant advances have been made in recent years highlighting the importance of skin-associated microbial communities to dermatological health [4–6]. Bacteria comprise the largest proportion of the microbiome, however fungi are ubiquitous on the skin but at a lower diversity than their bacterial counterparts. Thus, interkingdom interactions within the skin microbiome are omnipresent and represent a rich source of unexplored biology. Dysbiosis induced by fungal overgrowth is a phenomenon increasingly understood to contribute to chronic diseases in both the skin and gut. Moreover, antifungal therapeutics are severely lacking in the clinic making fungal infection among one of the most difficult diseases to manage and being associated to one of the skin diseases with the highest economic burden.
Although we have only begun to shed light on how fungi function within the skin microbiome, fungal colonization has already been shown to be important during early life, throughout key developmental stages, and into adulthood as we age, impacting dermatological health and disease outcomes in both humans and non-human vertebrates. Here, we review recent advances towards the study of fungi within the skin microbiome and their association health and disease. We further highlight the gaps in fundamental knowledge regarding host-microbe and microbe-microbe interactions that still exist.
Early Life and Development of the Skin Mycobiome
Microbial colonization during infancy is critical in the development of skin homeostasis. From birth, delivery mode determines whether acquired microbiota resemble those of maternal skin or vaginal microbiota [7,8]. Characterization of fungal communities overtime has revealed that delivery mode influences colonization by Candida species, where the relative abundances of Candida albicans is higher on the skin of infants delivered vaginally while Candida orthopsilosis is higher in the oral cavity of C-section-born infants over the first 30 days of life [9]. However, a study of term and preterm neonates examined clinical and host determinants that may influence the skin mycobiome [10] and found Malassezia, Candida, Cladosporium, Fusarium, and Cryptococcus were the most abundant genera and did not differ between the groups but fungal alpha and beta diversity varied with both clinical and host factors [10]. This suggests initial colonization by birth mode is more important than gestational age at birth. Conversely, constant changes in the skin physiology and a rapidly evolving infant microbiome over the first few months of life contribute to skin disorders, such as infant dermatitis (i.e., diaper rash). In a clinical study examining healthy infants and those with diaper dermatitis, C. albicans was more abundant in areas with skin-to-skin contact, whereas Cladosporium and Alternaria were more abundant in less occluded areas. Candida abundance directly correlated with disease severity [11]. Together, these findings reveal that shifts in clinical and host factors and skin microenvironments directly shape the skin mycobiome and dynamics during early life development.
To understand how the skin microbiome transitions towards adulthood, longitudinal studies have examined puberty-associated shifts [12]. Significant shifts in microbial community composition are associated with Tanner sexual maturation stages (Figure 1). Further, microbial changes appear to be sex specific with Cutibacterium and Malassezia as the dominant taxa in female children, whereas Corynebacterium, Staphylococcus, Streptococcus, and Haemophilus are the dominant taxa in male children. Fungal communities between sexes exhibited no significant differences, however sebaceous skin showed tighter clustering that is driven by Malassezia in female children compared to male children. Lipophilic species, including Cutibacterium and Malassezia, also exhibit strong association with several serum sex hormones [12], suggesting that the microbial transitions during puberty are mediated by sex hormone concentrations that subsequently increase sebaceous gland activity. Skin aging also influences the microbiome. It was recently reported that fungal communities on the forehead and cheek are significantly different and impacted by age (Figure 1) when including healthy young (19–28 years old) and older (60–63 years old) Korean women [13]. Further, the younger group exhibited higher network densities on the cheek and associations were found between low-abundance bacteria and fungi, including M. sympodialis, Gemella, and Methylobacterium, indicating the potential role of these species in aging. Overall, throughout the life span, the skin fungal and bacterial communities are dynamic and are influenced by numerous factors, working harmoniously to form a stable and homeostatic skin barrier. Due to the ease by which skin can be repeatedly sampled across diverse microenvironments, continued study of fungal-bacterial behaviors on the skin during normal human development presents an immense opportunity towards understanding species interactions in a community context and their role in host development. Furthermore, general principles gleaned from the cutaneous ecosystem can be generally applied to other host-associated microbial communities.
Skin Associated Fungi and Dermatological Diseases
Although overall fungal phylogenetic diversity on the skin is low, shifts in fungal abundance and expansion have been associated with numerous dermatological diseases. Malassezia species are the most prevalent fungal taxa found on human skin, acquiring lipids exogenously from skin secretions and generally living in a commensal state. However, this is context-dependent with several skin disorders associated with Malassezia, the most common being pityriasis versicolor and seborrheic dermatitis. The causal role of Malassezia in skin barrier diseases such as atopic dermatitis (AD) and psoriasis is less clear. Certain species including M. sloofiae, obtusa, and yamatoensis were found to be exclusively associated with AD samples along with an increase in the overall fungal diversity compared to healthy controls [4]. This is in contrast to a loss of bacterial diversity in AD patients, usually driven by the expansion of Staphylococcal bacteria species, i.e. S. aureus [5]. Thus, in AD, increased prevalence of Malassezia may simply be a consequence of disrupted bacterial communities. Concurrently, Malassezia will aggravate cutaneous inflammation through IL-23 and IL-17 dependent mechanisms only under conditions where skin integrity is impaired, such as during an AD flare [6]. The observation that fungal diversity increases as overall bacterial diversity decreases suggests a dynamic, yet stable ecosystem composed of fungal-bacterial networks on the skin. Fungal expansion may drive inflammatory responses during a skin barrier breach. The mechanisms governing these interactions remain largely unknown and represent an important area of future research.
Although Malassezia dominates human skin, Candida spp. are opportunistic fungal pathogens also commonly found on human skin. The presence of fungi in chronic wounds such as diabetic foot ulcers can have major consequences. We have shown that fungi are significantly associated with tissue necrosis and amputation. They can also serve as a scaffold for colonizing bacteria to bind and develop biofilms [14,15]. Skin-associated bacterial species have been shown to directly interact with C. albicans through cell surface macromolecules, such as fungal agglutin-like sequence (Als) proteins targeting Staphylococcal spp. [16]. We recently demonstrated that bacterial mannose binding lectins (fim operon) expressed by a wound isolate of Citrobacter freundii mediate attachment to the fungal cell wall [15]. We investigated the growth dynamics of C. albicans with C. freundii and observed an increase in fungal filamentation during biofilm formation [15]. C. albicans biofilm extracellular matrix can inhibit the release of neutrophil extracellular traps, or NETs, which are web-like structures consisting of DNA and antimicrobial proteins [17]. When human neutrophils are exposed to C. albicans biofilms alone or in combination with C. freundii, a significant increase in NET release under the co-culture exposure is observed [15]. Together, this suggests the fungal-bacterial interaction mediates the host inflammatory response. Thus, interkingdom interaction can result in emergent traits that influence pathogenesis. Identifying the signals driving these interactions will provide a framework to develop novel antimicrobial strategies targeted at polymicrobial infections.
The Emerging Pathogen Candida auris
In recent years, the fungal pathogen Candida auris has made headlines for its rapid emergence and alarming drug resistance profile. Multi-drug resistant and highly transmissive strains are commonly isolated from patients within care settings. Asymptomatic skin colonization is considered the primary mode of carriage, dissemination of C. auris, and a risk factor for subsequent bloodstream infection. C. auris can persistently colonize skin and environmental surfaces for long periods of time. Nett and colleagues used an ex vivo skin model to show that sweat and sebum secretions further enhance colonization and biofilm formation of C. auris on the skin surface compared to other Candida species [18]. Thus, decolonization, using antiseptics, represents a first line of defense to protect against invasive infection. Studies have demonstrated that C. auris colonizes mammalian skin better than C. albicans and has the ability to reside on the surface and within deeper tissue layers [18,19]. Strains from distinct clades can be further differentiated by their ability to colonize skin from diverse species including mice, pigs, and humans [18,19]. Studying this emerging pathogen to identify clade-specific signatures will permits reconstruction of traits conferring enhanced virulence and drug resistance on the skin though an evolutionary lens.
C. auris has been hypothesized to have emerged from marine environments. Strains related to clinical isolates have been found on the sandy beach and tidal swamp in the Andaman Islands, however they do not exhibit the same drug resistance profile of human-associated strains. A recent study screened seasonal tropical fruit as a potential reservoir of environmental C. auris and found the surfaces of stored apples, as opposed to freshly harvested apples, were colonized with high levels of antifungal resistant C. auris [20]. Apples are often treated with wax and agricultural fungicides acting as a potential source of selection pressure for antifungal resistance that could then disseminate into human populations. It is possible C. auris was transferred between fruit and skin of individuals during processing, raising important future research questions regarding the role of agricultural fungicides and food chain dynamics in the spread of emerging pathogens. Further, it remains unclear whether the healthy skin microbiome plays a role in host susceptibility to C. auris colonization, particularly in vulnerable older populations. One of the most common types of fungal infections worldwide is dermatophytic infection, affecting the skin and its appendages. Topical azoles, one of the largest antifungal groups, are often used for dermatophytoses. Studies have elucidated some possible mechanisms of azoles resistance in dermatophytes, including drug efflux, drug target modification, and upregulation of stress response [21]. The reliance of azoles to treat superficial mycoses has the potential to drive the emergence of drug resistance in C. auris in the skin environment. Further investigation into the use of topical antifungals and whether associations exist with the carriage C. auris is a critical gap that should be addressed.
Non-human Skin Mycobiome
Although the human skin microbiome is not as well studied as the gut microbiome, significant advances have been made in the study of non-human skin microbiomes. The amphibian skin microbiome has been best characterized within the last decade largely driven by conservation strategies to prevent species extinction due to devastating fungal infection. In addition to colonization resistance, it is also important to consider host-microbe interactions and their impact on the host’s health. Characterizing fungal-host associations, a recent study examined transition of the amphibian fungal community during host metamorphosis on the Colorado boreal toad [22]. From ITS fungal sequences, communities significantly varied across life stages of the toads and shared taxa between the host and habitat were observed. Interestingly, host-specific taxa were only observed during the egg life cycle, a sensitive period in the life cycle of this animal. As in other animals, fungal communities stabilize through maturity [22], highlighting similarities in the fungal communal shifts during maturation processes across different host species. In fish, fungi colonize at low abundance compared to bacteria, and the fungal community structure is clade-specific, where each clade harbors unique fungal communities. Further, cartilaginous fish show patterns of phylosymbiosis, while bony fish do not, which could stem from clade-specific microbial selection and maintenance [23]. Establishing a stable and unique skin microbiome could be impacted by changing ocean conditions and biological factors, such as sea surface temperature, chlorophyll a, and fish age, that has been shown in wild fish like the Pacific chub mackerel [24]. Unlike the human skin microbiome which exhibits temporal stability regardless of perturbations [25,26], the skin microbiome of vertebrates is affected by habitat, geographic location, season, and disease state. The effort of sampling vertebrate skin microbiota along with lifestyle and environmental changes will be crucial for future conservation strategies and broaden our view on how these key elements drive ecological functions across different hosts and environments (Table 1).
Table 1.
Host | Authors, date | Summary | Reference |
---|---|---|---|
Human | Findley et al., 2013 | Surveyed fungal community based on topography of the human skin. | [41] |
Oh et al., 2013 | Shift in the bacterial and fungal communities in patients with primary immunodeficiencies. | [42] | |
Oh et al., 2014 | The first multi-site metagenomic study of the human skin microbiome. | [3] | |
Findley and Grice, 2014 | Review of bacterial and fungal pathogens and their roles in skin disease. | [43] | |
Takemoto et al., 2015 | Molecular survey of skin fungal microbiota in patients with psoriasis. | [44] | |
Oh et al., 2016 | Explored temporal stability of bacteria, fungi and viruses on human skin. | [25] | |
Leung et al., 2016 | Characterization of the skin mycobiome of healthy, urban Chinese individuals. | [45] | |
Johnson et al., 2016 | C. albicans biofilms interactions with host neutrophil response. | [17] | |
Ward et al., 2018 | Temporal and topographical development of human mycobiome during the first month of life. | [9] | |
Tipton et al., 2018 | Fungi stabilize community network in the skin microbial ecosystems. | [46] | |
Han et al., 2018 | Analysis of the skin mycobiome in patients with atopic dermatitis. | [4] | |
Sparber et al., 2019 | The role of Malassezia spp. in regulating antifungal immunity and promoting skin inflammation in inflammatory skin disorders. | [6] | |
Paul et al., 2020 | Skin fungal communities of preterm and term neonates. | [10] | |
Flowers and Grice, 2020 | A review of colonization resistance in the human skin microbiome, highlighting the balance between risk and reward of commensal skin bacteria. | [2] | |
Horton et al., 2020 | Sweat and sebum secretions enhanced colonization and biofilm formation of C. auris on the skin surface compared to other Candida species using an ex vivo porcine skin model. | [18] | |
Teufel et al., 2021 |
Comparison of skin mycobiome between healthy and damage skin in infants with diaper dermatitis. | [11] | |
Barber and Zhang, 2021 | A review of small molecules produced by member of the human nasal/oral microbiome. | [34] | |
Cheong et al., 2021 | Priority effects and competitive exclusion on biofilm community structure in a community comprised of bacteria and fungi isolated from chronic wounds. | [15] | |
Huang et al., 2021 | Murine skin model to investigate C. auris colonization, host risk factors, and potential therapies. | [19] | |
Park et al., 2022 | Transitions of skin fungal and bacterial communities in healthy children during puberty. | [12] | |
Yadav et al., 2022 | Stored fruits as an environment contributing to development and spread of antifungal resistance C. auris. | [20] | |
Kim et al., 2022 | Age related changes in the skin microbiome and mycobiome in Korean women. | [13] | |
Animal | Kearns et al., 2017 | Explored antifungal properties of amphibian skin mycobiome. | [47] |
2018–2021 | Snake skin bacterial and fungal communities. | [48–50] | |
Chermprapai et al., 2019 | Comparison between healthy and atopic dermatitis dogs and their bacterial and fungal microbiota. | [51] | |
Niederle et al., 2019 | Skin-associated lactic acid bacteria from bullfrogs as potential biocontrol agents for fungal pathogens. | [37] | |
Greenspan et al., 2019 | Environmental effects on skin microbial assemblages and subsequent effects on host resistance to fungal pathogens. | [38] | |
Woodhams et al., 2020 | Modulations of amphibian skin defensive antifungal peptide and antifungal bacteria growth by probiotics. | [40] | |
2020 | Skin fungal microbiome of fish. | [23,24] | |
Vanderwolf et al., 2021 | Identifying fungal assemblages and key species based on susceptibility to white-nose syndrome in bats. | [36] | |
Alexiev et al., 2021 | Survey of skin fungal communities throughout metamorphic toad life stages. | [22] | |
2012–2019 | Antifungal metabolites derived from amphibian skin microbiome. | [52–56] |
Colonization Resistance in the Skin Microbiome
One function of the skin is to block pathogenic invasion. The diversity-invasibility hypothesis states that more diverse communities are more resistant to invasion than poorly diverse communities [27–29]. Resistance mechanisms against invading pathogens include production of antimicrobials [30–32], priming of the immune system [1], and utilization of metabolic niches [33]. Novel bioactive metabolites have been discovered from distinct locations on the human body. For example, in the oral microbiome, mutanobactin, mutanamide, and farnesol regulate C. albicans growth and development [34]. On the skin, bacterial-bacterial competition via metabolite production is well described between skin residents and pathogenic S. aureus [2,30–32], while the fungus M. globosa has been shown to secrete a protease, cleaving a major virulence factor of S. aureus and subsequently disrupting biofilm formation [2]. However, examples of bacterial antagonism towards fungi on human skin are lacking. This is somewhat surprising given the propensity of the skin microbiome to demonstrate antifungal colonization resistance in other animals; a recent example is in bats susceptible to white-nose syndrome (WNS) caused by the fungus Pseudogymnoascus destructans, a dermatophyte that manifests a ‘vampire-like’ lifestyle due to the lack of UV repair mechanisms [35,36]. Examining the skin microbiome in these animals showed that fungal community structure did not differ based on WNS-susceptibility, but several fungal species were differentially abundant on WNS-resistant hosts. Further, the yeast species Cutaneotrichosporon moniliiforme was found to inhibit P. destructans in vitro [36], highlighting the role of key members in the skin fungal assemblages in modulating disease resistance and colonization of pathogens.
Skin bacterial assemblages also contribute to colonization resistance in amphibians. For example, lactic acid bacteria that live on the skin of bullfrogs (i.e. Enterococcus gallinarum), have been shown to produce a wide range of anti-Batrachochytrium dendrobatidis (Bd) factors, the causative agent of the devastating fungal disease chytridiomycosis [37]. Further, environmental bacterial diversity and bioclimatic factors, such as temperature, precipitation, and elevation shape microbial community and structure of the skin microbiome, which in turn, are correlated to Bd infection intensity [38,39]. Metabolite-producing bacteria can also tune the host microbiome to dial up secondary defense mechanisms. For example, a novel skin defense peptide brevinine-1Ma was downregulated in probiotic-treated frogs, promoting growth of bacteria that had inhibitory activity against Bd [40]. Thus, to maintain and optimize colonization resistance, the host must acquire key beneficial bacterial and fungal taxa that engage in mutualistic and antagonistic interactions, while the environmental conditions must be preserved. Clear evidence is emerging of defensive symbiosis via production of antifungal factors in mammalian and amphibian skin microbiomes. Thus, the complexity and intricacy of the human skin microbiome makes it an excellent niche to discover novel bacterial-fungal interactions and small molecules that mediate these networks. Building off work in amphibians to explore bacterial antagonism towards fungi on human skin is an exciting direction of research to expedite the development of novel therapeutic drugs with minimal toxicity for superficial fungal infections.
Conclusions and Future Outlook
While the skin microbiome is composed of a large percentage of bacteria, fungi are key members participating in core functions related to the development, maintenance, and repair of the skin in vertebrate hosts. For the human skin microbiome, fungal communities are less diverse but universally present and change along with skin physiology and age. The question remains whether the bacterial communities contribute to the structure of the mycobiome including limiting pathogen expansion and promoting a less diverse community as one transitions into adulthood. It is likely that these changes in the skin fungal community serve an important ecological role. Understanding these shifts will provide insights into how the human host resists colonization of potential fungal invaders, a topic that has been well-studied in the context of conservation strategies for animals. Discovering these interactions could provide deeper insight into crucial players in the skin microbial community and their ecological functions. Potentially, this effort will lead to novel therapeutics and improve fungi-related dermatological outcomes.
Acknowledgements
The authors gratefully acknowledge members of the Kalan lab for thoughtful feedback on the manuscript. This work was supported by grants from the National Institutes of Health (NIAID U19AI142720, NIGMS R35 GM137828 [L.R.K], and NIGMS T32GM008349 [U.T.N]). The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.
References
- 1. Swaney MH, Kalan LR: Living in Your Skin: Microbes, Molecules, and Mechanisms. Infect Immun 2021, 89. * A review on microbe, host and immune interactions mediated by the skin microbiome during various skin conditions. The authors discussed the role of microbial metabolites in microbe-microbe and microbe-host interactions.
- 2. Flowers L, Grice EA: The Skin Microbiota: Balancing Risk and Reward. Cell Host Microbe 2020, 28:190–200. * A review on the risk and reward balance of the microbial ecosystem on the human skin, examining colonization resistance and the protective function of the host skin barrier against pathogens. The authors further provided evidence on how skin residents can cause skin disorders.
- 3.Oh J, Byrd AL, Deming C, Conlan S, Kong HH, Segre JA, Barnabas B, Blakesley R, Bouffard G, Brooks S, et al. : Biogeography and individuality shape function in the human skin metagenome. Nat 2014 5147520 2014, 514:59–64. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 4.Han SH, Cheon HI, Hur MS, Kim MJ, Jung WH, Lee YW, Choe YB, Ahn KJ: Analysis of the skin mycobiome in adult patients with atopic dermatitis. Exp Dermatol 2018, 27:366–373. [DOI] [PubMed] [Google Scholar]
- 5.Byrd AL, Deming C, Cassidy SKB, Harrison OJ, Ng WI, Conlan S, Belkaid Y, Segre JA, Kong HH: Staphylococcus aureus and Staphylococcus epidermidis strain diversity underlying pediatric atopic dermatitis. Sci Transl Med 2017, 9. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 6.Sparber F, De Gregorio C, Steckholzer S, Ferreira FM, Dolowschiak T, Ruchti F, Kirchner FR, Mertens S, Prinz I, Joller N, et al. : The Skin Commensal Yeast Malassezia Triggers a Type 17 Response that Coordinates Anti-fungal Immunity and Exacerbates Skin Inflammation. Cell Host Microbe 2019, 25:389–403.e6. [DOI] [PubMed] [Google Scholar]
- 7.Dominguez-Bello MG, Costello EK, Contreras M, Magris M, Hidalgo G, Fierer N, Knight R: Delivery mode shapes the acquisition and structure of the initial microbiota across multiple body habitats in newborns. Proc Natl Acad Sci U S A 2010, 107:11971–11975. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 8.Dominguez-Bello MG, De Jesus-Laboy KM, Shen N, Cox LM, Amir A, Gonzalez A, Bokulich NA, Song SJ, Hoashi M, Rivera-Vinas JI, et al. : Partial restoration of the microbiota of cesarean-born infants via vaginal microbial transfer. Nat Med 2016, 22:250. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 9.Ward TL, Dominguez-Bello MG, Heisel T, Al-Ghalith G, Knights D, Gale CA: Development of the Human Mycobiome over the First Month of Life and across Body Sites. mSystems 2018, 3. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 10.Paul AA, Hoffman KL, Hagan JL, Sampath V, Petrosino JF, Pammi M: Fungal cutaneous microbiome and host determinants in preterm and term neonates. Pediatr Res 2020, 88. [DOI] [PubMed] [Google Scholar]
- 11.Teufel A, Howard B, Hu P, Carr AN: Characterization of the microbiome in the infant diapered area: Insights from healthy and damaged skin. Exp Dermatol 2021, 30. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 12. Park J, Schwardt NH, Jo JH, Zhang Z, Pillai V, Phang S, Brady SM, Portillo JA, MacGibeny MA, Liang H, et al. : Shifts in the Skin Bacterial and Fungal Communities of Healthy Children Transitioning through Puberty. J Invest Dermatol 2022, 142. ** Implementing longitudinal studies, the authors investigated the impact of sexual maturation on the skin micro- and mycobiome during puberty. They found that microbial shifts were more associated with Tanner sexual maturation stages than chronological age.
- 13. Kim HJ, Oh HN, Park T, Kim H, Lee HG, An S, Sul WJ: Aged related human skin microbiome and mycobiome in Korean women. Sci Reports 2022 121 2022, 12:1–11. ** Bacterial and fungal communities of Korean women were examined to determine age-related features of the skin microbiomes. They found that the presence of different fungal species depends on skin regions and age. Further, sebum concentration and transepidermal water loss significantly decrease in older individuals, which suggests a link between skin physiology, microbiome, and aging. Through network analysis, younger skin microbial communities exhibited a more complex network and are connected by low-abundant species, demonstrating the inter-domain microbial associations in the skin.
- 14.Kalan L, Loesche M, Hodkinson BP, Heilmann K, Ruthel G, Gardner SE, Grice EA: Redefining the chronic-wound microbiome: Fungal communities are prevalent, dynamic, and associated with delayed healing. MBio 2016, 7. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 15. Cheong JZA, Johnson CJ, Wan H, Liu A, Kernien JF, Gibson ALF, Nett JE, Kalan LR: Priority effects dictate community structure and alter virulence of fungal-bacterial biofilms. ISME J 2021, doi: 10.1038/s41396-021-00901-5. ** Exploring priority effects and competitive exclusion in a polymicrobial biofilm composed of bacteria and fungi isolated from chronic wound, the authors found that C. albicans biofilms shape community structure and enhance binding of bacteria via mannose-binding lectins. Fungal-bacterial interactions further led to increased filamentation of C. albicans.
- 16.Carolus H, Van Dyck K, Van Dijck P: Candida albicans and Staphylococcus Species: A Threatening Twosome. Front Microbiol 2019, 10. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 17.Johnson CJ, Cabezas-Olcoz J, Kernien JF, Wang SX, Beebe DJ, Huttenlocher A, Ansari H, Nett JE: The Extracellular Matrix of Candida albicans Biofilms Impairs Formation of Neutrophil Extracellular Traps. PLoS Pathog 2016, 12. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 18. Horton M V, Johnson CJ, Kernien JF, Patel TD, Lam BC, Cheong JZA, Meudt JJ, Shanmuganayagam D, Kalan LR, Nett JE: Candida auris Forms High-Burden Biofilms in Skin Niche Conditions and on Porcine Skin. mSphere 2020, 5. * Using an ex vivo porcine skin model, this study revealed sweat and sebum secretions on the skin surface promote colonization and biofilm formation of C. auris compared to other Candida species, which explains the ability of C. auris to colonize the skin, persist on medical devices, and spread in healthcare settings.
- 19. Huang X, Hurabielle C, Drummond RA, Bouladoux N, Desai JV, Sim CK, Belkaid Y, Lionakis MS, Segre JA: Murine model of colonization with fungal pathogen Candida auris to explore skin tropism, host risk factors and therapeutic strategies. Cell Host Microbe 2021, 29:210–221.e6. ** The authors developed a novel murine skin topical model for C. auris colonization, assessing duration of C. auris colonization, strain-specific colonization ability, host risk factors, and potential therapeutics. This model provide a deeper understanding of C. auris pathogenesis, launching efforts in developing therapeutic strategies.
- 20. Yadav A, Jain K, Wang Y, Pawar K, Kaur H, Sharma KK, Tripathy V, Singh A, Xu J, Chowdhary A: Candida auris on Apples: Diversity and Clinical Significance. MBio 2022, 13. * Marine-associated C. auris strains do not possess the same antifungal resistance profile as observed in human-associated strains. This study investigated stored fruits as an environmental source of antifungal resistant C. auris due to the use of agricultural fungicides, highlighting the importance of agricultural biocontrol agents and their role in the emergence of pathogens.
- 21.Khurana A, Sardana K, Chowdhary A: Antifungal resistance in dermatophytes: Recent trends and therapeutic implications. Fungal Genet Biol 2019, 132:103255. [DOI] [PubMed] [Google Scholar]
- 22.Alexiev A, Chen MY, McKenzie VJ: Identifying fungal-host associations in an amphibian host system. PLoS One 2021, 16:e0256328. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 23.Doane MP, Morris MM, Papudeshi B, Allen L, Pande D, Haggerty JM, Johri S, Turnlund AC, Peterson M, Kacev D, et al. : The skin microbiome of elasmobranchs follows phylosymbiosis, but in teleost fishes, the microbiomes converge. Microbiome 2020, 8. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 24.Minich JJ, Petrus S, Michael JD, Michael TP, Knight R, Allen EE: Temporal, Environmental, and Biological Drivers of the Mucosal Microbiome in a Wild Marine Fish, Scomber japonicus. mSphere 2020, 5. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 25.Oh J, Byrd AL, Park M, Kong HH, Segre JA: Temporal Stability of the Human Skin Microbiome. Cell 2016, 165:854–866. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 26.Grice EA, Kong HH, Conlan S, Deming CB, Davis J, Young AC, Bouffard GG, Blakesley RW, Murray PR, Green ED, et al. : Topographical and temporal diversity of the human skin microbiome. Science (80-) 2009, 324:1190–1192. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 27.Mallon CA, Van Elsas JD, Salles JF: Microbial invasions: the process, patterns, and mechanisms. Trends Microbiol 2015, 23:719–729. [DOI] [PubMed] [Google Scholar]
- 28.Case TJ: Invasion resistance arises in strongly interacting species-rich model competition communities. Proc Natl Acad Sci U S A 1990, 87:9610–9614. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 29.Kennedy TA, Naeem S, Howe KM, Knops JMH, Tilman D, Reich P: Biodiversity as a barrier to ecological invasion. Nature 2002, 417:636–638. [DOI] [PubMed] [Google Scholar]
- 30.O’Sullivan JN, Rea MC, O’Connor PM, Hill C, Ross RP: Human skin microbiota is a rich source of bacteriocin-producing staphylococci that kill human pathogens. FEMS Microbiol Ecol 2019, 95. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 31.O’Sullivan JN, O’Connor PM, Rea MC, O’Sullivan O, Walsh CJ, Healy B, Mathur H, Field D, Hill C, Paul Ross R: Nisin J, a novel natural nisin variant, is produced by Staphylococcus capitis sourced from the human skin microbiota. J Bacteriol 2020, 202. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 32.Claesen J, Spagnolo JB, Ramos SF, Kurita KL, Byrd AL, Aksenov AA, Melnik AV, Wong WR, Wang S, Hernandez RD, et al. : A cutibacterium acnes antibiotic modulates human skin microbiota composition in hair follicles. Sci Transl Med 2020, 12. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 33.Erin Chen Y, Fischbach MA, Belkaid Y: Skin microbiota–host interactions. Nat 2018. 5537689 2018, 553:427–436. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 34.Barber CC, Zhang W: Small molecule natural products in human nasal/oral microbiota. J Ind Microbiol Biotechnol 2021, 48:10. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 35.Palmer JM, Drees KP, Foster JT, Lindner DL: Extreme sensitivity to ultraviolet light in the fungal pathogen causing white-nose syndrome of bats. Nat Commun 2017 91 2018, 9:1–10. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 36.Vanderwolf KJ, Campbell LJ, Goldberg TL, Blehert DS, Lorch JM: Skin fungal assemblages of bats vary based on susceptibility to white-nose syndrome. ISME J 2020 153 2020, 15:909–920. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 37.Niederle MV, Bosch J, Ale CE, Nader-Macías ME, Aristimuño Ficoseco C, Toledo LF, Valenzuela-Sánchez A, Soto-Azat C, Pasteris SE: Skin-associated lactic acid bacteria from North American bullfrogs as potential control agents of Batrachochytrium dendrobatidis. PLoS One 2019, 14:e0223020. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 38.Greenspan SE, Lyra ML, Migliorini GH, Kersch-Becker MF, Bletz MC, Lisboa CS, Pontes MR, Ribeiro LP, Neely WJ, Rezende F, et al. : Arthropod–bacteria interactions influence assembly of aquatic host microbiome and pathogen defense. Proc R Soc B 2019, 286. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 39.Ruthsatz K, Lyra ML, Lambertini C, Belasen AM, Jenkinson TS, da Silva Leite D, Becker CG, Haddad CFB, James TY, Zamudio KR, et al. : Skin microbiome correlates with bioclimate and Batrachochytrium dendrobatidis infection intensity in Brazil’s Atlantic Forest treefrogs. Sci Reports 2020 101 2020, 10:1–15. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 40. Woodhams DC, Rollins-Smith LA, Reinert LK, Lam BA, Harris RN, Briggs CJ, Vredenburg VT, Patel BT, Caprioli RM, Chaurand P, et al. : Probiotics Modulate a Novel Amphibian Skin Defense Peptide That Is Antifungal and Facilitates Growth of Antifungal Bacteria. Microb Ecol 2020, 79:192–202. ** Using antifungal-producing bacteria, the study demonstrated their ability in modulating the host microbiome to trigger secondary defense mechanisms. The presence of probiotic induced activation of a novel skin defense peptide brevinine-1Ma, promoting growth of bacteria that had inhibitory activity against fungal pathogen B. dendrobatidis.
- 41.Findley K, Oh J, Yang J, Conlan S, Deming C, Meyer JA, Schoenfeld D, Nomicos E, Park M, Kong HH, et al. : Topographic diversity of fungal and bacterial communities in human skin. Nat 2013 4987454 2013, 498:367–370. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 42.Oh J, Freeman AF, Park M, Sokolic R, Candotti F, Holland SM, Segre JA, Kong HH: The altered landscape of the human skin microbiome in patients with primary immunodeficiencies. Genome Res 2013, 23:2103–2114. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 43.Findley K, Grice EA: The Skin Microbiome: A Focus on Pathogens and Their Association with Skin Disease. PLOS Pathog 2014, 10:e1004436. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 44.Takemoto A, Cho O, Morohoshi Y, Sugita T, Muto M: Molecular characterization of the skin fungal microbiome in patients with psoriasis. J Dermatol 2015, 42:166–170. [DOI] [PubMed] [Google Scholar]
- 45.Leung MHY, Chan KCK, Lee PKH: Skin fungal community and its correlation with bacterial community of urban Chinese individuals. Microbiome 2016, 4:1–15. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 46.Tipton L, Müller CL, Kurtz ZD, Huang L, Kleerup E, Morris A, Bonneau R, Ghedin E: Fungi stabilize connectivity in the lung and skin microbial ecosystems. Microbiome 2018, 6:1–14. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 47.Kearns PJ, Fischer S, Fernández-Beaskoetxea S, Gabor CR, Bosch J, Bowen JL, Tlusty MF, Woodhams DC: Fight fungi with fungi: Antifungal properties of the amphibian mycobiome. Front Microbiol 2017, 8:2494. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 48.Allender MC, Baker S, Britton M, Kent AD: Snake fungal disease alters skin bacterial and fungal diversity in an endangered rattlesnake. Sci Reports 2018 81 2018, 8:1–9. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 49.Grioni A, To KW, Crow P, Rose-Jeffreys L, Ching KK, Chu LO, Hill FI, Chan HK, Cheung KS: Detection of Ophidiomyces ophidiicola in a Wild Burmese Python (Python bivittatus) in Hong Kong SAR, China. https://doi-org.ezproxy.library.wisc.edu/105818/JHMS-S-20-00018 2021, 31:283–291. [Google Scholar]
- 50.Walker DM, Leys JE, Grisnik M, Grajal-Puche A, Murray CM, Allender MC: Variability in snake skin microbial assemblages across spatial scales and disease states. ISME J 2019 139 2019, 13:2209–2222. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 51.Chermprapai S, Ederveen THA, Broere F, Broens EM, Schlotter YM, van Schalkwijk S, Boekhorst J, van Hijum SAFT, Rutten VPMG: The bacterial and fungal microbiome of the skin of healthy dogs and dogs with atopic dermatitis and the impact of topical antimicrobial therapy, an exploratory study. Vet Microbiol 2019, 229:90–99. [DOI] [PubMed] [Google Scholar]
- 52.Woodhams DC, LaBumbard BC, Barnhart KL, Becker MH, Bletz MC, Escobar LA, Flechas SV, Forman ME, Iannetta AA, Joyce MD, et al. : Prodigiosin, Violacein, and Volatile Organic Compounds Produced by Widespread Cutaneous Bacteria of Amphibians Can Inhibit Two Batrachochytrium Fungal Pathogens. Microb Ecol 2018, 75:1049–1062. [DOI] [PubMed] [Google Scholar]
- 53.Danevcic T, Vezjak MB, Tabor M, Zorec M, Stopar D: Prodigiosin induces autolysins in actively grown Bacillus subtilis cells. Front Microbiol 2016, 7:27. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 54.Danevčič T, Vezjak MB, Zorec M, Stopar D: Prodigiosin - A Multifaceted Escherichia coli Antimicrobial Agent. PLoS One 2016, 11:e0162412. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 55.Cauz ACG, Carretero GPB, Saraiva GKV, Park P, Mortara L, Cuccovia IM, Brocchi M, Gueiros-Filho FJ: Violacein targets the cytoplasmic membrane of bacteria. ACS Infect Dis 2019, 5:539–549. [DOI] [PubMed] [Google Scholar]
- 56.Durán M, Ponezi AN, Faljoni-Alario A, Teixeira MFS, Justo GZ, Durán N: Potential applications of violacein: A microbial pigment. Med Chem Res 2012, 21:1524–1532. [Google Scholar]